Robert E. Landry, EVP Finance CFO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 4,681 shares at $669.48 ($3.1M) on 2021-12-10, disclosed to the SEC on 2021-12-10.
Seasonal sale ($3.1M) by EVP Finance CFO — this insider has traded REGN in December in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $657.11 | 3,469 | $2.3M | 73.8% |
| 2 | $656.46 | 2 | $1K | 0.0% |
| 3 | $657.53 | 50 | $33K | 1.1% |
| 4 | $658.52 | 11 | $7K | 0.2% |
| 5 | $659.49 | 4 | $3K | 0.1% |
| 6 | $661.48 | 25 |
| $17K |
| 0.5% |
| 7 | $662.06 | 123 | $81K | 2.6% |
| 8 | $662.06 | 123 | $81K | 2.6% |
| 9 | $663.41 | 19 | $13K | 0.4% |
| 10 | $664.71 | 15 | $10K | 0.3% |
| 11 | $665.44 | 18 | $12K | 0.4% |
| 12 | $666.19 | 68 | $45K | 1.5% |
| 13 | $667.80 | 7 | $5K | 0.2% |
| 14 | $668.21 | 178 | $119K | 3.9% |
| 15 | $668.21 | 178 | $119K | 3.9% |
| 16 | $669.48 | 130 | $87K | 2.8% |
| 17 | $669.48 | 130 | $87K | 2.8% |
| 18 | $670.13 | 58 | $39K | 1.3% |
| 19 | $671.42 | 14 | $9K | 0.3% |
| 20 | $672.30 | 59 | $40K | 1.3% |
| Total | $659.56 avg | 4,681 | $3.1M | 100% |
| Filing → |
| REGN | SELL | 2023-08-25 | $188K | — | Filing → |
| REGN | SELL | 2023-03-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-02-07 | $2.1M | — | Filing → |